ArticleNaunyn-Schmiedeberg's archives of pharmacology2026
Pan-cancer characterization of the pyrimidine catabolic enzyme UPB1 identifies a tumor-suppressive prognostic biomarker in skin cutaneous melanoma.
Yingli Men et al.PubMed ↗Publisher ↗
No numbers read from the abstract.